- Global Pharma News & Resources
25-May-2021 - 27-May-2021

3rd Microbiome Movement - Maternal and Infant Health Summit 2021

Engage in this highly Immersive Platform and Capitalize on the Collaboration Between Industry and Academia to Explore Preventative and Therapeutic Treatment of the Microbiome During Pregnancy and Early Life.

This digital summit remains the only place for both industry and academia to come together to share the latest research and discoveries
with the overarching aim of studying the impact of the early microbiome on a myriad of diseases.

The world is waking up to the importance of preventative measures to treat diseases from the offset and there is no better time to start than infancy. The microbiome plays an unquantifiable role in allergic, inflammatory, metabolic and developmental sequalae.

Join the 3rd Microbiome Movement - Maternal and Infant Health Summit 2021 as we unite the greatest minds and engage over 3 days to dive deeply into a broad array of clinical areas.

This remains your best opportunity to learn and interact with the best thinkers in the field and update your knowledge for researching and developing clinically significant health products.

Early booking and group discounts apply and academic rates are available - see the website for details.


Speakers: Camilla Martin, Associate Professor of Pediatrics, Harvard Medical School, Victoria Niklas, Global Head Medical Affairs, Takeda, Liza Konnikova, Assistant Professor, Yale University School of Medicine, Dorottya Nagy-Szaka,l Chief Medical Officer, Biotia, Inc., Mara Couto-Rodriguez, Director of R and D, Biotia, Lorenzo Corsini, Co-Founder and CEO, PhagoMed, David Kyle, Chairman and CEO, Evolve Biosystems, Nikole Kimes, Founder and CEO, Siolta Therapeutics, Tal Korem, Assistant Professor, Department of Systems Biology, Columbia University, Greg Medlock, Assistant Professor, University of Virginia, Anita Kozyrskyj, Research Chair and Professor - Pediatrics, University of Alberta, Fernanda Rosa, Postdoctoral Researcher, University of Arkansas for Medical Sciences, Nurry Hong, CEO, ParetoBio, David Sela, Associate Professor, University of Massachusetts, Andrew A. Bremer, Chief, Pediatric Growth and Nutrition Branch, NICHD/NIH, Gregory Lambert, CEO and VP of RandD, TargEDys, Siobhain O'Mahony, Senior Lecturer, University of Cork, Christopher Stewart, Research Fellow and Group Leader, Newcastle University, Mary Claire Kimmel, Assistant Professor and Co-Director Perinatal Psychiatry Program, UNC School of Medicine, Stacy Kahn, Director, FMT and Microbial Therapeutics Program and Attending Physician, Inflammatory Bowel Disease Center, Boston Children's Hospital, Helen Vuong, Postdoctoral Fellow, University of California, Los Angeles, Trevor Lawley, Group Leader, Wellcome Trust Sanger Institute, David Donabedian, Co-founder and CEO, Axial Therapeutics Inc, Petter Brodin, Associate Professor of Immunology, Karolinska Institutet